Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Cumberland Pharmaceuticals Inc. (CPIX) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$39.55M
Net Income	$-6.28M
Cost of Goods Sold	$6.07M
Gross Profit	$33.49M
Operating Expenses	$49.11M
Operating Income	$-9.55M
Non-Operating Income/Expense	$3.27M
Pre-Tax Income	$-6.29M
Normalized Pre-Tax Income	$-6.29M
Income after Taxes	$-6.33M
Income from Continuous Operations	$-6.33M
Consolidated Net Income/Loss	$-6.33M
Normalized Income after Taxes	$-6.33M
EBIT	$-9.55M
EBITDA	$-1.27M
Weighted-Average Shares Outstanding (Basic)	14.30M
Weighted-Average Shares Outstanding (Diluted)	14.30M
Earnings per Share (EPS) (Basic)	$-0.44
Earnings per Share (EPS) (Diluted)	$-0.44
Balance Sheet Financials
Current Assets	$35.71M
Property, Plant, and Equipment	$0.37M
Long-Term Assets	$46.06M
Total Assets	$81.78M
Current Liabilities	$27.98M
Long-Term Debt	$12.78M
Long-Term Liabilities	$24.53M
Total Liabilities	$52.52M
Common Equity	$29.26M
Tangible Shareholders Equity	$5.74M
Shareholders Equity	$29.26M
Common Shares Outstanding	14.12M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.09M
Cash Flow from Investing Activities	$-0.11M
Cash Flow from Financial Activities	$-7.42M
Beginning Cash	$19.76M
End Cash	$18.32M
Increase/Decrease in Cash	$-1.44M
Stock-Based Compensation	$0.36M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.28
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.30
Debt to Equity Ratio	0.44
Gross Margin	84.66%
Operating Margin	-24.16%
EBIT Margin	-24.16%
EBITDA Margin	-3.22%
Pre-Tax Profit Margin	-15.89%
Profit Margin	-15.88%
Free Cash Flow	$5.81M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.48
Inventory Turnover	1.32
Receiveable Turnover	4.05
Days Sales in Receivables	90.05
Return on Equity	-21.64%
Return on Tangible Equity	-110.33%
Return on Assets	-7.74%
Return on Investments	-15.06%
Book Value Per Share	$2.07
Free Cash Flow per Share	$0.41
Operating Cash Flow per Share	$0.43

Data from Zacks Investment Research, Inc.